Ileal Pouch Studies
VSL#3® in the Dietary Management of an Ileal Pouch
The median stool frequency of pouch patients consuming VSL#3® on a daily basis progressively decreased ( P<0.01 at 3 months; P<0.001 at 6, 9, and 12 months)1. Further, the median Inflammatory Bowel Disease Questionnaire (IBDQ) score improved significantly in patients consuming VSL#3® compared to those receiving placebo ( P<0.001)20.

VSL#3® in the Dietary Management of Pouchitis
VSL#3® is the only probiotic recognized as an effective tool for the dietary management of pouchitis by the American College of Gastroenterology32 and the German Association of Gastroenterology25. Three double blind, placebo controlled trials have been published which shows that VSL#3® aids in the dietary management of pouchitis.19,20,44

Original Articles of VSL#3® in the Dietary Management of an Ileal Pouch
Mimura T et al: Gut 2004; 53:108-114.
Gionchetti P et al: Gastroenterology 2003; 124:1202-09.
Gionchetti P et al: Gastroenterology 2000; 119:305-309.
